| Serial Number | 88013735 |
| Word Mark | EVEREST CLINICAL RESEARCH |
| Filing Date | Monday, June 25, 2018 |
| Status | 702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED |
| Status Date | Thursday, September 12, 2024 |
| Registration Number | 5684749 |
| Registration Date | Tuesday, February 26, 2019 |
| Mark Drawing | 3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, December 11, 2018 |
| Description of Mark | The mark consists of the word "EVEREST" represented in stylized font primarily in blue letters with the first letter "E" appears in light blues shades and is larger in size than the following letters, and wherein the first letter "E is superimposed across a design consisting of two overlapping triangles, also varying in color between light and dark shades of blue. Additionally, the wording "CLINICAL RESEARCH" is located underneath "EVEREST" and the design and appears in smaller size font in the color black. |
| Indication of Colors claimed | The color(s) blue and black is/are claimed as a feature of the mark. |
| NOT AVAILABLE | "CLINICAL RESEARCH" |
| Goods and Services | Biomedical, pharmaceutical, biotechnology and health-related research study services, namely, conducting clinical trials in the field of clinical trials of drugs, medical devices and other interventions to determine efficacy and safety, namely, particularly, providing the selection of trial subjects in accordance with research design criteria, trial management and site monitoring, monitoring trial participants for adverse reactions and preparation and presentation of reports of adverse reactions, administration of clinical trial data and safety monitoring boards, collection and management of study data, clinical data management services and medical coding, analysis of study data including selection and application of statistical tests to study data, providing biostatistics and statistical programming, dispensing drugs and managing drug inventories, monitoring design and conduct of trials for compliance with applicable regulations and policies and preparation and presentation of compliance reports, development and maintenance of Internet websites for reporting on studies, medical writing and graphic design of research study protocols, preparation of reports of research studies and abstracts of reports, preparation and presentation of reports to study sponsors and regulatory authorities |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Saturday, June 30, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, October 21, 2003 |
| First Use In Commerce Date | Tuesday, October 21, 2003 |
| Party Name | EVEREST CLINICAL RESEARCH CORPORATION |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Ontario L3R0B8 CA |
| Party Name | EVEREST CLINICAL RESEARCH CORPORATION |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Ontario L3R0B8 CA |
| Party Name | EVEREST CLINICAL RESEARCH CORPORATION |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Ontario L3R0B8 CA |
| Event Date | Event Description |
| Saturday, June 30, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, June 28, 2018 | NEW APPLICATION ENTERED |
| Friday, October 19, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 3, 2018 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Monday, October 15, 2018 | ASSIGNED TO EXAMINER |
| Tuesday, October 16, 2018 | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY |
| Tuesday, October 16, 2018 | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED |
| Tuesday, October 16, 2018 | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Tuesday, October 16, 2018 | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED |
| Thursday, October 18, 2018 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, October 18, 2018 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, October 18, 2018 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, November 2, 2018 | ASSIGNED TO LIE |
| Wednesday, November 21, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, December 11, 2018 | PUBLISHED FOR OPPOSITION |
| Tuesday, December 11, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, February 26, 2019 | REGISTERED-PRINCIPAL REGISTER |
| Monday, February 26, 2024 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Friday, March 1, 2024 | TEAS SECTION 8 & 15 RECEIVED |
| Thursday, September 12, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Thursday, September 12, 2024 | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. |
| Thursday, September 12, 2024 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED |